Alcon voluntarily recalled the CyPass micro-stent in October, citing safety data from a 5-year study showing significant endothelial loss. The article was the most-read ophthalmology story of 2018 on Healio.com/OSN.
Here is the list of the year’s top 10 stories:
 
Alcon calls for surgeons to stop implanting CyPass micro-stent
The decision was based on safety data from the COMPASS-XT study, which found a statistically significant difference in endothelial cell loss at 5 years after surgery in patients who received the device in conjunction with cataract surgery compared to those who

Alcon voluntarily recalled the CyPass micro-stent in October, citing safety data from a 5-year study showing significant endothelial loss. The article was the most-read ophthalmology story of 2018 on Healio.com/OSN.
Here is the list of the year’s top 10 stories:
 
Alcon calls for surgeons to stop implanting CyPass micro-stent
The decision was based on safety data from the COMPASS-XT study, which found a statistically significant difference in endothelial cell loss at 5 years after surgery in patients who received the device in conjunction with cataract surgery compared to those who